Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | RAB9A | P51151 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.41 |
| ▸ | HTT | P42858 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | USP2 | O75604 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Noreximide SCHEMBL16664270 | 1.00 | ALDH1A1 (0.48) | ALDH1A1TDP1RAB9AMEN1KMT2A | |
| Noreximide SCHEMBL2109030 | 1.00 | ALDH1A1 (0.48) | ALDH1A1TDP1RAB9AMEN1KMT2A | |
| Noreximide SCHEMBL572054 | 1.00 | ALDH1A1 (0.48) | ALDH1A1TDP1RAB9AMEN1KMT2A | |
| Noreximide SCHEMBL1105956 | 1.00 | ALDH1A1 (0.48) | ALDH1A1TDP1RAB9AMEN1KMT2A | |
| Noreximide SCHEMBL14536593 | 1.00 | ALDH1A1 (0.48) | ALDH1A1TDP1RAB9AMEN1KMT2A | |
| Noreximide SCHEMBL24120970 | 1.00 | ALDH1A1 (0.48) | ALDH1A1TDP1RAB9AMEN1KMT2A | |
| Noreximide SCHEMBL17369118 | 1.00 | ALDH1A1 (0.48) | ALDH1A1TDP1RAB9AMEN1KMT2A | |
| Noreximide SCHEMBL9073180 | 1.00 | ALDH1A1 (0.48) | ALDH1A1TDP1RAB9AMEN1KMT2A | |
| Noreximide SCHEMBL17875126 | 1.00 | ALDH1A1 (0.48) | ALDH1A1TDP1RAB9AMEN1KMT2A | |
| SCHEMBL16275149 | 0.88 | ALDH1A1 (0.39) | ALDH1A1TDP1RAB9AMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1320 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122036591-A | Production method of hexafluorophosphate product | 河北圣泰材料股份有限公司 | 2026-05-15 | — | — | CN | claimed |
| US-20260115329-A1 | BIORESORBABLE CROSSLINKED HYDROGELS WITH ENHANCED RADIOPACITY FOR MEDICAL APPLICATIONS | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2026-04-30 | — | — | US | claimed |
| WO-2026090380-A1 | BIORESORBABLE CROSSLINKED HYDROGELS WITH ENHANCED RADIOPACITY FOR MEDICAL APPLICATIONS | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2026-04-30 | — | — | WO | claimed |
| US-20260041822-A1 | Bottlebrush and Multi-Arm Polymers for Medical Applications | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2026-02-12 | — | — | US | claimed |
| US-20250345488-A1 | CROSSLINKED HYDROGELS WITH ENHANCED RADIOPACITY FOR MEDICAL APPLICATIONS | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2025-11-13 | — | — | US | claimed |
| EP-4607278-A1 | CHEMICALLY-AMPLIFIED POSITIVE PHOTORESIST COMPOSITION FOR PATTERN PROFILE IMPROVEMENT AND ETCH RESISTANCE ENHANCEMENT | Ycchem Co., Ltd. (KR) | 2025-08-27 | — | — | EP | claimed |
| CN-120192263-A | Preparation of 2- (endo-5-norbornene-2, 3-dicarboximide) -1, 3-tetramethylurea hexafluorophosphate | 张家港市国泰华荣化工新材料有限公司 | 2025-06-24 | — | — | CN | claimed |
| US-20250199405-A1 | CHEMICALLY-AMPLIFIED POSITIVE PHOTORESIST COMPOSITION FOR PATTERN PROFILE IMPROVEMENT AND ETCH RESISTANCE ENHANCEMENT | YCCHEM CO., LTD. (KR) | 2025-06-19 | — | — | US | claimed |
| CN-120136859-A | Binaphthyl structure-assisted chiral pyridine oxazoline ligand, preparation method and application thereof | 华东理工大学 | 2025-06-13 | — | — | CN | claimed |
| CN-119019649-B | Cycloolefin polymer and preparation method thereof | 中石油(上海)新材料研究院有限公司 | 2025-06-03 | — | — | CN | claimed |
| WO-2008106334-A2 | FLAME RETARDED STYRENIC POLYMER FOAMS AND FOAM PRECURSORS | ALBEMARLE CORPORATION (US) | 2008-09-04 | — | — | WO | claimed |
| US-20080050631-A1 | Fuel Cell System and Composition for Electrode | NISSAN MOTOR CO., LTD. | 2008-02-28 | — | — | US | claimed |
| US-20080044709-A1 | Fuel Cell System and Solid Polymer Electrolyte Film | NISSAN MOTOR CO., LTD. | 2008-02-21 | — | — | US | claimed |
| EP-1042315-B1 | CYCLIC IMIDE-SUBSTITUTED PYRIDYLALKANE, ALKENE, AND ALKINE CARBOXAMIDES USEFUL AS CYTOSTATIC AND IMMUNOSUPPRESSIVE AGENTS | KLINGE CO CHEM PHARM FAB (DE) | 2004-04-14 | — | — | EP | claimed |
| EP-0307553-B1 | Modified splenopentines, their process of preparation and their use | BERLIN CHEMIE AG (DE) | 1994-06-15 | — | — | EP | claimed |
| US-5278246-A | Radial base block copolymer of monovinyl aromatic hydrocarbon polymer blocks and an olefin compound polymer block composed mainly of conjugated diene, diene moiety being hydrogenated; at least one unsaturated dicarboxylic acid unit grafted to it | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1994-01-11 | — | — | US | claimed |
| US-4966923-A | CONTAINING (METH)ALKYL SUBSTITUTED BICYCLO(2.2.1)HEP-5-ENE-2,3-DICARBOXYLIC ACID IMIDE AND ACRYLATED ESTER | CIBA-GEIGY CORPORATION (US) | 1990-10-30 | — | — | US | claimed |
| EP-0371001-A2 | A modified block copolymer | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1990-05-30 | — | — | EP | claimed |
| EP-0262691-A2 | A modified block copolymer | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1988-04-06 | — | — | EP | claimed |
| US-4039491-A | IMPACT STRENGTH, NORBORNENE DERIVATIVE CONTAINING POLAR GROUP | JAPAN SYNTHETIC RUBBER CO., LTD. (JA) | 1977-08-02 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260041822-A1 | Bottlebrush and Multi-Arm Polymers for Medical Applications | BRDT, CD44, KLK3 | ALDH1A1 220/4885TDP1 3463/4885RAB9A 4718/4885 |
| US-20260115329-A1 | BIORESORBABLE CROSSLINKED HYDROGELS WITH ENHANCED RADIOPACITY FOR MEDICAL APPLICATIONS | RAD54L, EGFR, ARG1 | ALDH1A1 334/4885TDP1 1151/4885RAB9A 1174/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.